Rates of Adverse Events and Multiple Sclerosis Relapses Before and After Introduction of a Purported Generic Glatiramer Acetate in mexico- Results from a Large Patient Support Program in Mexico
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.050
https://www.valueinhealthjournal.com/article/S1098-3015(15)02126-9/fulltext
Section Title :
Research Podium Presentations - Session 1
Section Order :
2803
First Page :
A877
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02126-9&doi=10.1016/j.jval.2015.09.050